Drug profile · INN
lenvatinib mesylate
LENVIMA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lenvatinib mesylate (LENVIMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN lenvatinib mesylate
Brand LENVIMA
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is lenvatinib mesylate?
lenvatinib mesylate (LENVIMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lenvatinib mesylate?
LENVIMA is a marketed brand name for lenvatinib mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lenvatinib mesylate?
lenvatinib mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.